Insider filing · SRZN

TCG Crossover GP II, LLC bought $1.2M of Surrozen (SRZN)

Executed Mar 12, disclosed Mar 16, 4 days later.

Over the 21 trading sessions from the disclosed entry session (Mar 16), the stock returned +25.2% (delay-adjusted); from the execution session (Mar 12), +4.6%. Derived: entry at the session's open, exit at the close 20 sessions later.

TL TCG Crossover GP II, LLC 10% owner profile →

TCG Crossover GP II, LLC (10% owner) filed 4 Form 4 reports as a reporting entity in the trailing twelve months (3 purchases, 1 sale), most often in Surrozen, Inc. (SRZN). Across 3 priced purchase filings, the average 21-session return was +12.8% from execution and +16.1% from disclosure (delay-adjusted; derived). The largest single filing was $6.9M of SRZN (325,000 sh across 2 lots, as filed), executed Jul 22.

SRZN Surrozen, Inc. SRZN · Healthcare · 16 filings in 24 months ticker →

Healthcare · Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→